Simulations Plus to Participate in the Stephens Annual Investment Conference
Simulations Plus (Nasdaq: SLP), a leading biosimulation and medical communications solutions provider for the biopharma industry, announced its participation in the Stephens Annual Investment Conference in Nashville. CEO Shawn O'Connor will engage in a fireside chat on November 20, 2024, at 12:00 p.m. Eastern Time and conduct one-on-one investor meetings throughout the day. The presentation will be available via live audio webcast, with a 90-day replay accessible on the company's Investors page.
Simulations Plus (Nasdaq: SLP), un fornitore leader di biosimulazioni e soluzioni di comunicazione medica per l'industria biopharma, ha annunciato la sua partecipazione alla Conferenza Annuale sugli Investimenti di Stephens a Nashville. Il CEO Shawn O'Connor parteciperà a una chiacchierata informale il 20 novembre 2024, alle 12:00 ora orientale, e condurrà incontri individuali con gli investitori durante tutta la giornata. La presentazione sarà disponibile tramite webcast audio dal vivo, con una registrazione accessibile per 90 giorni sulla pagina Investor dell'azienda.
Simulations Plus (Nasdaq: SLP), un proveedor líder de biosimulaciones y soluciones de comunicación médica para la industria biopharma, anunció su participación en la Conferencia Anual de Inversiones de Stephens en Nashville. El CEO Shawn O'Connor participará en una charla informal el 20 de noviembre de 2024, a las 12:00 p.m. hora del Este, y llevará a cabo reuniones individuales con inversionistas durante todo el día. La presentación estará disponible a través de una transmisión de audio en vivo, con una repetición accesible durante 90 días en la página de Inversores de la compañía.
Simulations Plus (Nasdaq: SLP)는 바이오제약 산업을 위한 선두적인 바이오 시뮬레이션 및 의료 커뮤니케이션 솔루션 제공업체로, 내슈빌에서 열리는 스티븐스 연례 투자 회의에 참여한다고 발표했습니다. CEO Shawn O'Connor는 2024년 11월 20일 동부 표준시로 오후 12시에 담화 세션을 진행하며, 하루 종일 투자자와의 일대일 회의를 진행할 예정입니다. 발표 내용은 실시간 오디오 웹캐스트를 통해 제공되며, 회사의 투자자 페이지에서 90일 간 재생이 가능합니다.
Simulations Plus (Nasdaq: SLP), un acteur majeur des solutions de biosimulation et de communication médicale pour l'industrie biopharmaceutique, a annoncé sa participation à la Conférence Annuelle d'Investissement de Stephens à Nashville. Le PDG Shawn O'Connor participera à une discussion informelle le 20 novembre 2024 à 12h00, heure de l'Est, et réalisera des réunions individuelles avec les investisseurs tout au long de la journée. La présentation sera disponible via un webcast audio en direct, avec une rediffusion accessible pendant 90 jours sur la page des investisseurs de la société.
Simulations Plus (Nasdaq: SLP), ein führender Anbieter von Biosimulationen und medizinischen Kommunikationslösungen für die Biopharma-Branche, hat seine Teilnahme an der Stephens Jahrestagung in Nashville bekannt gegeben. CEO Shawn O'Connor wird am 20. November 2024 um 12:00 Uhr Eastern Time an einem informellen Gespräch teilnehmen und den ganzen Tag über persönliche Treffen mit Investoren abhalten. Die Präsentation wird über einen Live-Audio-Webcast verfügbar sein, mit einer 90-tägigen Wiederholung, die auf der Investorenseite des Unternehmens zugänglich ist.
- None.
- None.
The live audio webcast of Mr. O’Connor’s fireside chat can be accessed via this link and also on the Investors page of the Simulations Plus website where the replay will be available for 90 days following the event.
About Simulations Plus
With more than 25 years of experience serving clients globally, Simulations Plus stands as a premier provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. Our comprehensive biosimulation solutions integrate artificial intelligence/machine learning (AI/ML), physiologically based pharmacokinetics, physiologically based biopharmaceutics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. We also deliver simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Our cutting-edge technology is licensed and utilized by leading pharmaceutical, biotechnology, and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com. Follow us on LinkedIn | X | YouTube.
Environmental, Social, and Governance (ESG)
We focus our Environmental, Social, and Governance (ESG) efforts where we can have the most positive impact. To learn more about our latest initiatives and priorities, please visit our website to read our 2023 ESG update.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241106293615/en/
Investor Relations Contacts:
Lisa Fortuna
Financial Profiles
310-622-8251
slp@finprofiles.com
Cristin Ryman
Simulations Plus Investor Relations
984-444-8358
cristin.ryman@simulations-plus.com
Source: Simulations Plus, Inc.
FAQ
When is Simulations Plus (SLP) presenting at the Stephens Annual Investment Conference 2024?
How can investors access the Simulations Plus (SLP) fireside chat at the Stephens Conference?
What type of presentation will Simulations Plus (SLP) deliver at the Stephens Conference 2024?
Where is the 2024 Stephens Annual Investment Conference being held for Simulations Plus (SLP)?
